Want to see NRIX full AI Analyst Report?
Nurix Therapeutics (NRIX) Ownership Overview
0.17% Insiders
17.91% Mutual Funds
59.24% Other Institutional Investors
17.11% ETFs
5.58% Public Companies and
Individual Investors
The ownership structure of Nurix Therapeutics (NRIX) stock is a mix of institutional, retail, and individual investors. Approximately 94.25% of the company’s stock is owned by Institutional Investors, 0.17% is owned by Insiders, and 5.58% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $43502935 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $25812786 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $104813438 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $8963221 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,262,098 | Institution | 5.07% | 140,550,638 | |
| 4,957,789 | Institution | 4.78% | 132,422,544 | |
| 4,658,556 | Institution | 4.49% | 124,430,031 | |
| 4,320,422 | Institution | 4.16% | 115,398,472 | |
| 4,308,703 | Institution | 4.15% | 115,085,457 | |
| 2,901,354 | Institution | 2.80% | 77,495,165 | |
| 1,838,283 | Institution | 1.77% | 49,100,539 | |
| 1,793,196 | Institution | 1.73% | 47,896,265 | |
| 1,517,575 | Institution | 1.46% | 40,534,428 | |
| 1,423,860 | Institution | 1.37% | 38,031,301 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,308,703 | Institution | 4.15% | 115,085,457 | |
| 1,517,575 | Institution | 1.46% | 40,534,428 | |
| 1,423,860 | Institution | 1.37% | 38,031,301 | |
| 1,323,464 | Institution | 1.28% | 35,349,723 | |
| 1,215,025 | Institution | 1.17% | 32,453,318 | |
| 1,145,329 | Institution | 1.10% | 30,591,738 | |
| 1,074,324 | Institution | 1.04% | 28,695,194 | |
| 945,380 | Institution | 0.91% | 25,251,100 | |
| 893,327 | Institution | 0.86% | 23,860,764 | |
| 598,762 | Institution | 0.58% | 15,992,933 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,290,002 | Institution | 3.17% | 76,360,946 | |
| 2,608,275 | Institution | 2.51% | 70,293,011 | |
| 2,474,242 | Institution | 2.38% | 66,087,004 | |
| 1,765,414 | Institution | 1.70% | 47,154,208 | |
| 1,120,373 | Institution | 1.08% | 26,003,857 | |
| 730,171 | Institution | 0.70% | 19,502,867 | |
| 686,932 | Institution | 0.66% | 18,347,954 | |
| 538,018 | Institution | 0.52% | 12,487,398 | |
| 460,441 | Institution | 0.44% | 12,408,885 | |
| 330,159 | Institution | 0.32% | 8,818,547 |
FAQ
Who Owns Nurix Therapeutics, Inc. (NRIX)?
According to the latest TipRanks data, approximately 59.24% of the company's stock is held by institutional investors, 0.17% is held by insiders, and 5.58% is held by retail investors.
What percentage of Nurix Therapeutics, Inc. (NRIX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 59.24% of Nurix Therapeutics, Inc. (NRIX) stock is held by institutional investors.
What percentage of Nurix Therapeutics, Inc. (NRIX) stock is held by retail investors?
According to the latest TipRanks data, approximately 5.58% of Nurix Therapeutics, Inc. (NRIX) stock is held by retail investors.
Who owns the most shares of Nurix Therapeutics, Inc. (NRIX)?
Vanguard owns the most shares of Nurix Therapeutics, Inc. (NRIX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.